Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, is hosting a corporate exhibition stand at the Growth Company Investor Show to be held at The Barbican Exhibition Halls, London, on Wednesday 11 June 2008.
The Company’s management team, including John Dawson, Chief Executive, and Richard Wright, Finance Director, look forward to welcoming investors and potential investors to Stand No 64 and providing an insight into recent progress at the Company.
At its recent AGM, Alliance Pharma reported that trading in the first four months of 2008 was “substantially ahead of the same period the previous year.”
Alliance Pharma’s annual report, and further information about the Company, is available at the Company’swebsite, www.alliancepharma.co.uk.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.